Stoke Therapeutics, Inc. (NASDAQ:STOK) has 178 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 5,623,525 | 76,669 | 1.38% | $183,101,974.00 |
| FMR LLC | 31 Mar, 2026 | 5,600,920 | -1,264,137 | -18.41% | $177,773,201.00 |
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 5,546,856 | 423,331 | 8.26% | $176,057,209.00 |
| Lynx1 Capital Management LP | 31 Mar, 2026 | 5,404,674 | 0 | 0.00% | $171,544,353.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 5,385,714 | 173,160 | 3.32% | $175,358,848.00 |
| FMR LLC | 31 Mar, 2026 | 5,383,666 | -217,254 | -3.88% | $175,292,165.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 5,212,554 | -774,887 | -12.94% | $165,446,463.00 |
| Lynx1 Capital Management LP | 31 Mar, 2026 | 4,763,673 | -641,001 | -11.86% | $155,105,193.00 |
| Redmile Group, LLC | 31 Mar, 2026 | 4,164,120 | 130,050 | 3.22% | $135,583,747.00 |
| Redmile Group, LLC | 31 Mar, 2026 | 4,034,070 | -141,472 | -3.39% | $128,041,382.00 |
| Morgan Stanley | 31 Mar, 2026 | 3,546,158 | 9,108 | 0.26% | $112,555,054.00 |
| Morgan Stanley | 31 Mar, 2026 | 3,423,280 | -122,878 | -3.47% | $111,461,996.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 3,336,697 | 0 | 0.00% | $108,642,854.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 3,336,697 | -1,297,141 | -27.99% | $105,906,763.00 |
| Toronto Dominion Bank | 31 Mar, 2026 | 3,173,258 | 0 | 0.00% | $100,719,209.00 |
| Toronto Dominion Bank | 31 Mar, 2026 | 3,173,258 | 0 | 0.00% | $103,321,280.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 3,149,239 | -14,635 | -0.46% | $99,956,846.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 3,095,700 | 2,359,901 | 320.73% | $100,795,992.00 |
| BVF INC/IL | 31 Mar, 2026 | 2,547,557 | 281,883 | 12.44% | $82,948,456.00 |
| State Street Corp | 31 Mar, 2026 | 2,498,049 | 1,072,176 | 75.19% | $79,288,075.00 |